CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $172,000 | -20.4% | 71,591 | -2.3% | 0.00% | – |
| Q4 2020 | $216,000 | +113.9% | 73,286 | +11.5% | 0.00% | – |
| Q3 2020 | $101,000 | -45.4% | 65,753 | -11.2% | 0.00% | – |
| Q2 2020 | $185,000 | +38.1% | 74,030 | +12.9% | 0.00% | – |
| Q1 2020 | $134,000 | -34.0% | 65,555 | 0.0% | 0.00% | – |
| Q4 2019 | $203,000 | -6.9% | 65,555 | +0.3% | 0.00% | – |
| Q3 2019 | $218,000 | +4.8% | 65,387 | +0.4% | 0.00% | – |
| Q2 2019 | $208,000 | +13.7% | 65,125 | +2.2% | 0.00% | – |
| Q1 2019 | $183,000 | -29.3% | 63,753 | -1.0% | 0.00% | -100.0% |
| Q4 2018 | $259,000 | +29.5% | 64,395 | +50.3% | 0.00% | – |
| Q3 2018 | $200,000 | -46.5% | 42,832 | -5.8% | 0.00% | -100.0% |
| Q2 2018 | $374,000 | – | 45,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |